Where the mon­ey is: Biotech’s megahubs com­mand VC's bil­lions

 

When it comes to the ge­og­ra­phy of biotech mon­ey, there’s the Bay Area/Sil­i­con Val­ley and the Boston/Cam­bridge hub at the epi­cen­ter of the North­east’s key re­gion.

And then there’s every­thing else.

As part of a se­ries on ven­ture cap­i­tal and biotech, End­points asked the an­a­lysts at Thom­son Reuters to run the num­bers on where the life sci­ences in­vest­ment mon­ey flowed last year. They tracked  $3.5 bil­lion for Sil­i­con Val­ley plus the Bay Area and $2.8 bil­lion for New Eng­land. Bro­ken down by city, $6.1 bil­lion went to Boston ($2.7 bil­lion), San Jose ($2.5 bil­lion) and San Fran­cis­co/Berke­ley ($1 bil­lion).

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.